trial · primary record
Atezolizumab
Metastatic Lung Non-Small Cell Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 53 |
| Primary completion | 2027-10-03 |
| Primary endpoint | Number of Participants With a Durable Response |
| Registry ID | NCT03600701 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:36.206Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03600701
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.